Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Bacteria in the oral cavity” refers to a vast and diverse community of microorganisms inhabiting the human mouth, collectively known as the **oral microbiota** or **oral microbiome**. This community comprises over 700–1,000 bacterial species spanning at least 12 major phyla, including Firmicutes, Proteobacteria, Bacteroidetes, Fusobacteria, and Actinobacteria, among others. Oral bacteria occupy various niches such as the tongue, dental surfaces, gingival crevice, buccal mucosa, and saliva, exhibiting high inter-individual and site-specific diversity. Most of the oral bacteria are commensal or mutualistic, contributing to the maintenance of oral health by outcompeting pathogens and regulating immune responses. However, shifts in the community (dysbiosis) can promote the dominance of pathogenic species, leading to diseases such as dental caries and periodontitis and contributing to systemic conditions like cardiovascular disease and inflammatory bowel disease. Therefore, “bacteria in the oral cavity” are better viewed as a functional ecosystem rather than a single therapeutic target or molecule; specific pathogenic strains within this group are legitimate targets for therapy and disease prevention. Note on correctness: "Bacteria in the oral cavity" is not a molecule, single protein, or receptor but rather a heterogeneous, ecological grouping. If a specific bacterial species or a defined virulence factor is meant as the therapeutic target, it should be named more precisely (e.g., "Streptococcus mutans adhesin" or "Porphyromonas gingivalis gingipain").
Disruption of bacterial cell wall/membrane integrity; Inhibition of protein or nucleic acid synthesis (antibiotics); Inhibition of adherence or biofilm formation; Modulation of microbial composition (probiotics); Immunomodulatory effects leading to bacterial clearance
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterium in the oral cavity.